Pre-surgical Androgen Deprivation Therapy With or Without Axitinib in Previously Untreated Prostate Cancer Patients With Known or Suspected Lymph Node Metastasis
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Axitinib (Primary) ; Antiandrogens
- Indications Prostate cancer
- Focus Therapeutic Use
- 26 Jun 2017 Planned End Date changed from 1 Mar 2018 to 1 Mar 2019.
- 26 Jun 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.
- 10 Jun 2017 Biomarkers information updated